Trailing-twelve-month (TTM) net income is $10.55 Billion with a year-over-year change of (48.28%). Net income represents the company's bottom line profit after all expenses, taxes, and interest.
Reported quarterly net income; no daily interpolation. Q1 FY2027 (2026-06-30): $1.56B.
Net Income growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:02:53.000Z. Historical observations retain their original dates. Historical series through 2026-09-09.
$10.55B
$10.55 Billion
(48.28%)
vs. $20.40B a year ago (TTM)
(14.13%)
5 Year compound annual growth rate
1 Year
(48.28%)
3 Year
(4.43%)
5 Year
(14.13%)
10 Year
+3.52%
15 Year
+31.80%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Net Income | YoY Change | % Change |
|---|---|---|---|
| 2026 | $15.01B | ($2.91B) | (16.24%) |
| 2025 | $17.92B | +$6.85B | +61.82% |
| 2024 | $11.08B | +$481.42M | +4.54% |
| 2023 | $10.60B | +$782.09M | +7.97% |
| 2022 | $9.81B | ($13.16B) | (57.29%) |
| 2021 |
TTM Growth
(48.28%)
3-Year CAGR
(4.43%)
5-Year CAGR
(14.13%)
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-09-09T20:02:53.000Z. Historical observations retain their original dates. Historical series through 2026-09-09.
| $22.97B |
| +$1.88B |
| +8.92% |
| 2020 | $21.09B | +$8.00B | +61.07% |
| 2019 | $13.10B | +$2.88B | +28.18% |
| 2018 | $10.22B | +$3.87B | +61.10% |
| 2017 | $6.34B | ($4.73B) | (42.71%) |
